{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:28Z","timestamp":1786993528798,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jval.2025.03.019","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:14:59Z","timestamp":1744733699000},"page":"1091-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Hannah M.","family":"Worboys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica Hern\u00e1ndez","family":"Alava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharlene","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jval.2025.03.019_bib2","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/ndt\/gfac170","article-title":"Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire","volume":"37","author":"Worboys","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.jval.2025.03.019_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-015-0312-9","article-title":"Reporting statement for studies mapping onto generic preference-based outcome measures: explanation and elaboration","volume":"33","author":"Petrou","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2025.03.019_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jval.2025.03.019_bib6","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2589-7500(23)00204-2","article-title":"Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK","volume":"6","author":"Greenwood","year":"2024","journal-title":"Lancet Digit Health"},{"issue":"5","key":"10.1016\/j.jval.2025.03.019_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00451725","article-title":"Development of the kidney disease quality of life (KDQOL) instrument","volume":"3","author":"Hays","year":"1994","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jval.2025.03.019_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.jval.2025.03.019_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol - a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"8","key":"10.1016\/j.jval.2025.03.019_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"issue":"34","key":"10.1016\/j.jval.2025.03.019_bib12","first-page":"1","article-title":"Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods","volume":"24","author":"Alava","year":"2020"},{"issue":"2","key":"10.1016\/j.jval.2025.03.019_bib13","article-title":"Mapping MOS-HIV to HUI3 and EQ-5D-3L in patients with HIV","volume":"2","author":"Joyce","year":"2017","journal-title":"MDM Policy Pract"},{"issue":"4","key":"10.1016\/j.jval.2025.03.019_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jval.2015.02.016","article-title":"Modeling health state utility values in ankylosing spondylitis: comparisons of direct and indirect methods","volume":"18","author":"Wailoo","year":"2015","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.03.019_bib15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1186\/s12885-021-08964-5","article-title":"Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer","volume":"21","author":"Gray","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jval.2025.03.019_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jval.2011.12.014","article-title":"Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values","volume":"15","author":"Hern\u00e1ndez Alava","year":"2012","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2025.03.019_bib17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s10198-019-01088-5","article-title":"Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis","volume":"20","author":"Yang","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"10","key":"10.1016\/j.jval.2025.03.019_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae273","article-title":"Sex and gender differences in health-related quality of life in individuals treated with incremental and conventional hemodialysis","volume":"17","author":"Riehl-Tonn","year":"2024","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.jval.2025.03.019_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","article-title":"Mapping to estimate health-state utility from non\u2013preference-based outcome measures: an ISPOR good practices for outcomes research task force report","volume":"20","author":"Wailoo","year":"2017","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2025.03.019_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0272989X15613522","article-title":"Measuring the sensitivity and construct validity of 6 utility instruments in 7 disease areas","volume":"36","author":"Richardson","year":"2016","journal-title":"Med Decis Mak"},{"issue":"2","key":"10.1016\/j.jval.2025.03.019_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2025.03.019_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40258-019-00467-6","article-title":"An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values","volume":"17","author":"Mukuria","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"10.1016\/j.jval.2025.03.019_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-018-0857-3","article-title":"Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement","volume":"16","author":"Dakin","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2025.03.019_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jval.2025.03.019_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40273-023-01285-4","article-title":"Catalogues of EQ-5D-3L health-related quality of life scores for 199 chronic conditions and health risks for use in the UK and the USA","volume":"41","author":"Falk","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jval.2025.03.019_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/0272989X13500720","article-title":"A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes","volume":"34","author":"Hern\u00e1ndez Alava","year":"2013","journal-title":"Med Decis Mak"},{"issue":"6","key":"10.1016\/j.jval.2025.03.019_bib27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jval.2017.09.017","article-title":"Development of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3","volume":"21","author":"Gray","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.03.019_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.ajkd.2016.05.022","article-title":"Establishing core outcome domains in hemodialysis: report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop","volume":"69","author":"Tong","year":"2017","journal-title":"Am J Kidney Dis"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525023022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525023022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:51:59Z","timestamp":1762365119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525023022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1098301525023022"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.03.019","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}